Business
Perimeter Medical Imaging AI Announces Publication of New Clinical Evidence Featuring Case Studies from Commercial Use of Perimeter S-Series OCT
Perimeter Medical Imaging AI Announces Publication of New Clinical Evidence Featuring Case Studie...
About this update from Perimeter Medical Imaging Ai Inc
[{"type":"text","content":"\n \n \n \n Perimeter Medical Imaging AI Announces Publication of New Clinical Evidence Featuring Case Studies from Commercial Use of Perimeter S-Series OCT\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n TORONTO\n \n and\n \n DALLAS\n \n \n ,\n \n \n March 29, 2023\n \n \n /CNW/ - (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) – Perimeter Medical Imaging AI, Inc. (\"Perimeter\" or the \"Company\") – a commercial-stage medical technology company – announced the publication of a\n \n \n new white paper\n \n \n entitled \"Use of adjunct wide-field optical coherence tomography to visualize margins during breast conserving surgery for ductal carcinoma\n \n in situ\n \n : a case series,\" which features three case studies from the commercial use of its innovative Perimeter S-Series OCT technology.\n \n \n \n \n \n \n \n \n \n Perimeter S-Series OCT is an ultra-high-resolution medical imaging tool with FDA 510(k) clearance that uses Optical Coherence Tomography (OCT) to provide clinicians with cross-sectional, real-time margin visualization 1-2 mm below the surface of an excised tissue specimen.\n \n \n Dr.\n \n Amelia Tower\n \n , a board-certified general surgeon with advanced training in breast surgical oncology based in\n \n Fort Worth, TX\n \n , authored the paper and describes how she integrated the Perimeter S-Series OCT system into her breast oncology practice. She concludes that when assisted by Perimeter S-Series OCT in these three case studies, she was able to make intraoperative clinical decisions to excise additional tissue during the primary surgeries, sparing the three patients the need for a second surgery and relieving the associated burden on clinical, economic, and psychosocial resources.\n \n \n \n Jeremy Sobotta\n \n , Perimeter's Chief Executive Officer stated, \"We are encouraged and excited by the results from the case studies featured in this newly published white paper. We believe that bringing Perimeter's transformative ultra-high resolution medical imaging technology directly into the O...